Results 221 to 230 of about 332,876 (331)

IRC14-1299-A methodology to induce lodging at plot scale in the field [PDF]

open access: yes, 2014
Dingkuhn, Michaël   +3 more
core  

Selenomethionine Regulates the Arachidonic Acid Metabolism‐Ferroptosis‐Inflammation Axis to Ameliorate Colitis

open access: yesAnimal Research and One Health, EarlyView.
Selenomethionine can ameliorate arachidonic acid‐induced colonic injury through synergistic mechanisms, including alleviating inflammatory responses, improving barrier integrity, enhancing antioxidant capacity by upregulating selenoprotein expression, selectively regulating AA metabolism to reduce pro‐inflammatory oxylipins and promote the production ...
Huihui Tian   +8 more
wiley   +1 more source

Geophysical Investigations at the Artemision at Amarynthos of Euboea (Greece)

open access: yesArchaeological Prospection, EarlyView.
ABSTRACT A combination of resistivity mapping and three‐dimensional electrical resistivity tomography (ERT) was used to investigate the subsurface of the sanctuary of Artemis Amarysia in Amarynthos, Euboea (Greece), an area where archaeological remains from the Bronze Age to the post‐Byzantine period are preserved.
G. N. Tsokas   +5 more
wiley   +1 more source

Engineering properties and rock mass classification of Karacay Dam derivation tunnel (Hatay-Turkey) [PDF]

open access: yes, 2016
Altındag, R.   +5 more
core  

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel

open access: yesArthritis &Rheumatology, EarlyView.
Objective Vacuoles E1 enzyme X‐linked autoinflammatory somatic syndrome (VEXAS) is a recently identified rare genetic disorder associated with somatic mutations in the UBA1 gene. VEXAS presents with a combination of inflammatory and hematologic manifestations, leading to increased morbidity and mortality.
Arsene Mekinian   +111 more
wiley   +1 more source

Identification of histone deacetylase inhibitor targeting type I interferon and B‐cell abnormalities in systemic lupus erythematosus

open access: yesArthritis &Rheumatology, Accepted Article.
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy